MMP-9/RECK imbalance: A mechanism associated with high-grade cervical lesions and genital infection by human papillomavirus and chlamydia trachomatis

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1539-1547

  Discacciati, Michelle G ^a   Gimenes, Fabrícia ^b   Pennacchi, Paula C ^a   Faião Flores, Fernanda ^a   Zeferino, Luiz C ^c   Derchain, Sophie M ^c   Teixeira, Júlio C ^c   Costa, Maria C ^d   Zonta, Marco ^e   Termini, Lara ^d   Boccardo, Enrique ^a   Longatto Filho, Adhemar ^a,f,g,h   Consolaro, Marcia E L ^b   Villa, Luisa L ^a,d   Maria Engler, Silvya S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF MARINGÁ   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF MINHO   (Portugal)

^g UNIVERSITY OF MINHO   (Portugal)

^h BARRETOS CANCER HOSPITAL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; PROTEINASE; RECK PROTEIN; UNCLASSIFIED DRUG; BACTERIAL DNA; DNA; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; RECK PROTEIN, HUMAN; VIRUS DNA;

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CANDIDIASIS; CARCINOGENESIS; CERVICAL CARCINOGENESIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; GENE EXPRESSION; GENOTYPE; GENOTYPING TECHNIQUE; GONORRHEA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROORGANISM DETECTION; MIXED INFECTION; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMA HOMINIS; MYCOPLASMA HOMINIS INFECTION; NEISSERIA GONORRHOEAE; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SYPHILIS; TREPONEMA PALLIDUM; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROBIOLOGY; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; UTERINE CERVICITIS; UTERINE CERVIX; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; DNA, BACTERIAL; DNA, NEOPLASM; DNA, VIRAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; GPI-LINKED PROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; VAGINAL SMEARS;

EID: 84942915607     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0420     Document Type: Article

References (40)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
2. Kang Y, Pantel K. Tumor or cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 2013; 23:573-81.
3. Libra M, Scalisi A, Vella N, Clementi S, Sorio R, Stivala F, et al. Uterine cervical carcinoma: role of matrix metalloproteinases (review). Int J Oncol 2009;34:897-903.
4. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010;141:52-67.
5. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007;8:221-33.
6. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-29.
7. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-74.
8. No JH, JoH, Kim SH, Park IA, Kang D, Lee CH, et al. Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia. Ann N Y Acad Sci 2009;1171:100-4.
9. Li Y, Wu T, Zhang B, Yao Y, Yin G. Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer. Med Oncol 2012; 29:3394-9.
10. da Silva Cardeal LB, Brohem CA, Corrêa TC, Winnischofer SM, Nakano F, Boccardo E, et al. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol 2006;84:713-9.
11. Cardeal LB, Boccardo E, Termini L, Robachini T, Andreoli MA, di Loreto C, et al. HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis. PLoS ONE 2012;7:e33585.
12. Matheus ER, Zonta MA, Discacciati MG, Paruci P, Velame F, Cardeal LB, et al. MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears. Diagn Cytopathol 2014;42: 827-33.
13. Marconi C, Santos-Greatti MM, Parada CM, Pontes A, Pontes AG, Giraldo PC, et al. Cervicovaginal levels of proinflammatory cytokines are increased during chlamydial infection in bacterial vaginosis but not in lactobacillidominated flora. J Low Genit Tract Dis 2014;18:261-5.
14. Boccardo E, Lepique AP, Villa LL. The role of inflammation in HPV carcinogenesis. Carcinogenesis 2010;31:1905-12.
15. Luostarinen T, Namujju PB, Merikukka M, Dillner J, Hakulinen T, Koskela P, et al. Order of HPV/Chlamydia infections and cervical high-grade precancer risk: A case-cohort study. Int J Cancer 2013;133:1756-9.
16. Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, et al. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: A cohort study. Sex Transm Infect 2014;90:550-5.
17. Ault KA, Kelly KA, Ruther PE, Izzo AA, Izzo LS, Sigar IM, et al. Chlamydia trachomatis enhances the expression ofmatrix metalloproteinases in an in vitro model of the human fallopian tube infection. Am J Obstet Gynecol 2002;187:1377-83.
18. Hu VH, Weiss HA, Ramadhani AM, Tolbert SB, Massae P, Mabey DC, et al. Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. Infect Immun 2012;80:121-30.
19. Snijders PJF, Steenbergen RDM, Heideman DAM, Meijer CJLM. HPVmediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006;208:152-64.
20. Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. 4th ed. Lyon, France: IARC; 2014.
21. Souza RP, de Abreu AL, Ferreira EC, Rocha-Brischiliari SC, de Carvalho BMD, Pelloso SM, et al. Simultaneous detection of seven sexually transmitted agents in human immunodeficiency virus-infected Brazilian women by multiplex polymerase chain reaction. Am J Trop Med Hyg 2013;30: 1199-202.
22. McIver CJ, Rismanto N, Smith C, Naing ZW, Rayner B, Lusk MJ, et al. Multiplex PCR testing detection of higher-than-expected rates of cervical Mycoplasma, Ureaplasma, and Trichomonas and viral agent infection in sexually Australian women. J Clin Microbiol 2009;47: 1358-63.
23. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301.
24. Jacomasso T, Trombetta-Lima M, Sogayar MC, Winnischofer SM. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2. Melanoma Res 2014;24:32-9.
25. Reis ST, Pontes-Junior J, Antunes AA, de Sousa-Canavez JM, Dall'Oglio MF, Passerotti CC, et al. MMP-9 overexpression due to TIMP-1 and RECK underexpression is associated with prognosis in prostate cancer. Int J Biol Markers 2011;26:255-61.
26. Chang CK, Hung WC, Chang HC. The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J Cell Mol Med 2008;12:2781-9.
27. Wang L, Wang Q, Li HL, Han LY. Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma-relationship with prognosis. Asian Pac J Cancer Prev 2013; 14:2113-8.
28. Ghosh A, Moirangthem A, Dalui R, Ghosh T, Bandyopadhyay A, Dasgupta A, et al. Expression of matrix metalloproteinase-2 and 9 in cervical intraepithelial neoplasia and cervical carcinoma among different age groups of premenopausal and postmenopausal women. J Cancer Res Clin Oncol 2014;140:1585-93.
29. Bulkmans NW, Bleeker MC, Berkhof J, Voorhorst FJ, Snijders PJ, Meijer CJ. Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer 2005;117:177-81.
30. Discacciati MG, da Silva ID, Villa LL, Reis L, Hayashi P, Costa MC, et al. Prognostic value ofDNAandmRNAe6/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2. Biomark Insights 2014;9:15-22.
31. Chumduri C, Gurumurthy RK, Zadora PK, Mi Y, Meyer TF. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response. Cell Host Microbe 2013;13: 746-58.
32. Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjänen K, et al. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 2008;51:230-4.
33. Silins I, Ryd W, Strand A, Wadell G, Törnberg S, Hansson BG, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005;116:110-5.
34. Silva J, Cerqueira F, Medeiros R. Response to: Chlamydia trachomatis, human papillomavirus, bacterial vaginosis, and cervical neoplasia. Arch Gynecol Obstet 2014;289:1157-8.
35. Roset Bahmanyar E, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, et al. HPV PATRICIA Study Group: prevalence and risk factors for cervical HPV infection and abnormalities in young adult women enrolled in the multinational PATRICIA trial. Gynecol Oncol 2012; 127:440-50.
36. Castellsagué X, Paavonen J, Jaisamrarn U, Wheeler CM, Skinner SR, Lehtinen M, et al. HPV PATRICIA Study Group. Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: Analysis of women in the control arm of the randomized, controlled PATRICIA trial. BMC Infect Dis 2014;14:551.
37. Oh HY, Seo SS, Kim MK, Lee DO, Chung YK, Lim MC, et al. Synergistic effect of viral load and alcohol consumption on the risk of persistent high-risk human papillomavirus infection. PLoS ONE 2014;9:e104374.
38. Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer 2014;135:453-66.
39. Ma YT, Collins SI, Young LS, Murray PG, Woodman CB. Smoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: A longitudinal study. Br J Cancer 2011;104:1500-4.
40. Zeferino LC, Derchain SF. Cervical cancer in the developing world. Best Pract Res Clin Obstet Gynaecol 2006;20:339-54.